The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19

Detalles Bibliográficos
Autores principales: Sadasivam, Balakrishnan, Atal, Shubham, Ray, Avik, Sharma, Swati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451053/
https://www.ncbi.nlm.nih.gov/pubmed/32861824
http://dx.doi.org/10.1016/j.ijid.2020.08.058
_version_ 1783574911930859520
author Sadasivam, Balakrishnan
Atal, Shubham
Ray, Avik
Sharma, Swati
author_facet Sadasivam, Balakrishnan
Atal, Shubham
Ray, Avik
Sharma, Swati
author_sort Sadasivam, Balakrishnan
collection PubMed
description
format Online
Article
Text
id pubmed-7451053
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-74510532020-08-28 The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19 Sadasivam, Balakrishnan Atal, Shubham Ray, Avik Sharma, Swati Int J Infect Dis Letter to the Editor The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020-11 2020-08-27 /pmc/articles/PMC7451053/ /pubmed/32861824 http://dx.doi.org/10.1016/j.ijid.2020.08.058 Text en © 2020 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Sadasivam, Balakrishnan
Atal, Shubham
Ray, Avik
Sharma, Swati
The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
title The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
title_full The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
title_fullStr The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
title_full_unstemmed The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
title_short The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
title_sort significance of correct dosing of hydroxychloroquine in clinical trials of covid-19
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451053/
https://www.ncbi.nlm.nih.gov/pubmed/32861824
http://dx.doi.org/10.1016/j.ijid.2020.08.058
work_keys_str_mv AT sadasivambalakrishnan thesignificanceofcorrectdosingofhydroxychloroquineinclinicaltrialsofcovid19
AT atalshubham thesignificanceofcorrectdosingofhydroxychloroquineinclinicaltrialsofcovid19
AT rayavik thesignificanceofcorrectdosingofhydroxychloroquineinclinicaltrialsofcovid19
AT sharmaswati thesignificanceofcorrectdosingofhydroxychloroquineinclinicaltrialsofcovid19
AT sadasivambalakrishnan significanceofcorrectdosingofhydroxychloroquineinclinicaltrialsofcovid19
AT atalshubham significanceofcorrectdosingofhydroxychloroquineinclinicaltrialsofcovid19
AT rayavik significanceofcorrectdosingofhydroxychloroquineinclinicaltrialsofcovid19
AT sharmaswati significanceofcorrectdosingofhydroxychloroquineinclinicaltrialsofcovid19

Ejemplares similares